237 related articles for article (PubMed ID: 24865448)
1. Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.
Mann JJ; Oquendo MA; Watson KT; Boldrini M; Malone KM; Ellis SP; Sullivan G; Cooper TB; Xie S; Currier D
Depress Anxiety; 2014 Oct; 31(10):814-21. PubMed ID: 24865448
[TBL] [Abstract][Full Text] [Related]
2. CSF GABA in depressed patients and normal controls.
Roy A; Dejong J; Ferraro T
Psychol Med; 1991 Aug; 21(3):613-8. PubMed ID: 1719577
[TBL] [Abstract][Full Text] [Related]
3. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
[TBL] [Abstract][Full Text] [Related]
5. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels.
Placidi GP; Oquendo MA; Malone KM; Huang YY; Ellis SP; Mann JJ
Biol Psychiatry; 2001 Nov; 50(10):783-91. PubMed ID: 11720697
[TBL] [Abstract][Full Text] [Related]
6. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
7. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia.
Roy A; Pickar D; Linnoila M; Doran AR; Ninan P; Paul SM
Psychiatry Res; 1985 Aug; 15(4):281-92. PubMed ID: 2415996
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
10. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
Pech J; Forman J; Kessing LV; Knorr U
J Affect Disord; 2018 Nov; 240():6-16. PubMed ID: 30041075
[TBL] [Abstract][Full Text] [Related]
11. No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover.
Mann JJ; Currier D; Murphy L; Huang YY; Galfalvy H; Brent D; Greenhill L; Oquendo M
J Affect Disord; 2008 Feb; 106(1-2):117-21. PubMed ID: 17604842
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
[TBL] [Abstract][Full Text] [Related]
14. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
Agren H
Psychiatry Res; 1980 Oct; 3(2):211-23. PubMed ID: 6171840
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
16. Lower CSF MHPG predicts short-term risk for suicide attempt.
Galfalvy H; Currier D; Oquendo MA; Sullivan G; Huang YY; John Mann J
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1327-35. PubMed ID: 19573266
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome.
Nisijima K; Ishiguro T
J Psychiatr Res; 1995; 29(3):233-44. PubMed ID: 7473299
[TBL] [Abstract][Full Text] [Related]
18. CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence.
Sher L; Oquendo MA; Grunebaum MF; Burke AK; Huang YY; Mann JJ
Eur Neuropsychopharmacol; 2007 Jan; 17(1):12-5. PubMed ID: 16762535
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients.
Berrettini WH; Nurnberger JI; Scheinin M; Seppala T; Linnoila M; Narrow W; Simmons-Alling S; Gershon ES
Biol Psychiatry; 1985 Mar; 20(3):257-69. PubMed ID: 2579681
[TBL] [Abstract][Full Text] [Related]
20. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
Gerner RH; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Hare TA; Shaywitz BA; Cohen DJ
Am J Psychiatry; 1984 Dec; 141(12):1533-40. PubMed ID: 6209989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
